SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.135
AS - Asia 3.620
EU - Europa 2.054
SA - Sud America 553
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 12.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.994
SG - Singapore 1.318
CN - Cina 962
BR - Brasile 419
VN - Vietnam 407
IT - Italia 378
DE - Germania 315
UA - Ucraina 315
HK - Hong Kong 272
GB - Regno Unito 231
FI - Finlandia 165
TR - Turchia 165
PL - Polonia 121
FR - Francia 111
BD - Bangladesh 109
RU - Federazione Russa 97
JP - Giappone 96
SE - Svezia 83
IN - India 70
CA - Canada 69
MX - Messico 52
ID - Indonesia 44
AR - Argentina 43
NL - Olanda 41
EE - Estonia 37
IQ - Iraq 29
ZA - Sudafrica 28
BE - Belgio 26
CO - Colombia 24
CZ - Repubblica Ceca 22
EC - Ecuador 22
ES - Italia 19
MA - Marocco 18
MY - Malesia 17
LT - Lituania 14
PK - Pakistan 14
PY - Paraguay 13
SA - Arabia Saudita 13
VE - Venezuela 12
IE - Irlanda 11
IR - Iran 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
PH - Filippine 10
AT - Austria 8
CL - Cile 8
ET - Etiopia 8
KE - Kenya 8
RO - Romania 8
EG - Egitto 7
JM - Giamaica 7
KR - Corea 7
NP - Nepal 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
PT - Portogallo 6
SD - Sudan 6
KZ - Kazakistan 5
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
EU - Europa 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
OM - Oman 4
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
PE - Perù 2
AW - Aruba 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GD - Grenada 1
GN - Guinea 1
Totale 12.456
Salva come PNG Salva come JPEG
Città #
Singapore 848
Ashburn 662
Woodbridge 521
San Jose 504
Fairfield 340
Jacksonville 331
Beijing 324
Chandler 324
Houston 314
Santa Clara 297
Ann Arbor 281
Hong Kong 264
Wilmington 139
Dallas 136
Ferrara 132
Ho Chi Minh City 132
Cambridge 113
Seattle 113
Nanjing 110
Warsaw 107
Los Angeles 101
Izmir 100
Tokyo 94
Munich 87
Princeton 81
Hanoi 80
New York 77
Boardman 69
Lauterbourg 62
Helsinki 61
Dearborn 57
Milan 49
São Paulo 41
Nanchang 37
Shanghai 37
Council Bluffs 36
Shenyang 35
Buffalo 34
San Diego 33
Turku 33
London 31
Tianjin 30
Changsha 29
Mexico City 29
Montreal 27
Orem 27
Bologna 26
Brussels 26
Chennai 23
Jakarta 22
Poplar 21
Da Nang 20
The Dalles 20
Bremen 19
Brooklyn 19
Denver 19
Frankfurt am Main 19
Brno 18
Chicago 18
Hefei 18
Jiaxing 17
Phoenix 17
Boston 16
Hebei 16
Toronto 16
Haiphong 15
Moscow 15
Ningbo 15
Orange 15
Stockholm 15
Addison 14
Atlanta 14
San Francisco 14
Jinan 13
Norwalk 13
Manchester 12
Philadelphia 12
San Mateo 12
Amsterdam 11
Dublin 11
Redwood City 11
Augusta 10
Hillsboro 10
Mountain View 10
Rome 10
Auburn Hills 9
Baghdad 9
Brasília 9
Charlotte 9
Curitiba 9
Dong Ket 9
Guangzhou 9
Johannesburg 9
Kraków 9
Ninh Bình 9
Quito 9
Tashkent 9
Washington 9
Kuala Lumpur 8
Paris 8
Totale 8.124
Salva come PNG Salva come JPEG
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 275
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 252
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 245
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 237
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 236
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 217
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 215
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 213
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 206
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 196
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 195
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 194
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 193
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 190
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 190
Mutual communication of envelope glycoproteins of paramixoviruses 189
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 189
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 189
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 188
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 186
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 184
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 181
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 180
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 176
Substrate binding to 6-phosphogluconate dehydrogenase 176
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 175
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 173
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 168
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 168
Biochemical study in adult population with stroke in Ferrara, Fabry disease 168
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 166
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 165
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 162
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 156
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 155
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 152
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 152
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 151
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 148
Domain structure of the hemagglutinin-neuraminidase from sendai virus 143
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 142
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 142
Purification of transglutaminase enzyme from L. infantum promastigotes 142
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 141
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 139
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 138
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 137
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 134
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 130
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 130
null 128
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 128
MMP-9 isoforms in serum of Multiple Sclerosis patients 127
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 125
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 124
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 124
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 123
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 122
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 122
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 119
Effects of anticoagulants on the activity of gelatinases 113
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 111
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 110
null 110
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 108
Effects of anticoagulants on the activity of gelatinases 107
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 106
null 104
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 104
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 103
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 102
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 101
null 97
The influence of different replacement solutions on neutrophils response 96
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 92
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 90
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 89
null 88
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 86
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 86
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 81
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 77
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 70
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 55
null 53
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease 50
null 49
Sex differences in biomarkers: Implications for age-related diseases 34
Sex and Gender in Ageing and Longevity: Highlights from an International Course 19
Totale 12.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 126
Totale 55.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20265.097 502 227 410 610 685 322 655 285 474 547 263 117
Totale 12.602